(1)
Febuxostat and Renal Outcomes in Stage 3-4 CKD Patients With Asymptomatic Hyperuricemia: A Prospective Observational Study. J Rang Med Col. 2026, 11 (1), 3-8. https://doi.org/10.3329/jrpmc.v11i1.89919.